| Literature DB >> 21522057 |
Adam Stewart1, Russell Riehl, Keith Wong, Jeremy Green, Jessica Cosgrove, Karoly Vollmer, Evan Kyzar, Peter Hart, Alexander Allain, Jonathan Cachat, Siddharth Gaikwad, Molly Hook, Kate Rhymes, Alan Newman, Eli Utterback, Katie Chang, Allan V Kalueff.
Abstract
3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') is a potent psychedelic drug inducing euphoria and hypersociability in humans, as well as hyperactivity and anxiety in rodents. Adult zebrafish (Danio rerio) have become a widely used species in neurobehavioral research. Here, we explore the effects of a wide range (0.25-120 mg/l) of acute MDMA doses on zebrafish behavior in the novel tank test. Although MDMA was inactive at lower doses (0.25-10 mg/l), higher doses reduced bottom swimming and immobility (40-120 mg/l) and impaired intrasession habituation (10-120 mg/l). MDMA also elevated brain c-fos expression, collectively confirming the usage of zebrafish models for screening of hallucinogenic compounds.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21522057 PMCID: PMC3083639 DOI: 10.1097/FBP.0b013e328345f758
Source DB: PubMed Journal: Behav Pharmacol ISSN: 0955-8810 Impact factor: 2.293